These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 21800009
1. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. Spectre G, Arnetz L, Östenson CG, Brismar K, Li N, Hjemdahl P. Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009 [Abstract] [Full Text] [Related]
2. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. Capodanno D, Patel A, Dharmashankar K, Ferreiro JL, Ueno M, Kodali M, Tomasello SD, Capranzano P, Seecheran N, Darlington A, Tello-Montoliu A, Desai B, Bass TA, Angiolillo DJ. Circ Cardiovasc Interv; 2011 Apr 01; 4(2):180-7. PubMed ID: 21386092 [Abstract] [Full Text] [Related]
3. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA. Diabetes; 2007 Dec 01; 56(12):3014-9. PubMed ID: 17848625 [Abstract] [Full Text] [Related]
7. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. Dillinger JG, Drissa A, Sideris G, Bal dit Sollier C, Voicu S, Manzo Silberman S, Logeart D, Drouet L, Henry P. Am Heart J; 2012 Oct 26; 164(4):600-606.e1. PubMed ID: 23067920 [Abstract] [Full Text] [Related]
12. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabaté M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, Macaya C, Fernandez-Ortiz A. J Am Coll Cardiol; 2010 Mar 16; 55(11):1139-46. PubMed ID: 20223369 [Abstract] [Full Text] [Related]
13. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Zisman E, Erport A, Kohanovsky E, Ballagulah M, Cassel A, Quitt M, Pizov R. Eur J Anaesthesiol; 2010 Jul 16; 27(7):617-23. PubMed ID: 20035230 [Abstract] [Full Text] [Related]
14. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF. Am Heart J; 2008 Jan 16; 155(1):93.e1-7. PubMed ID: 18082496 [Abstract] [Full Text] [Related]
15. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS. Thromb Haemost; 2008 Jul 16; 100(1):83-9. PubMed ID: 18612542 [Abstract] [Full Text] [Related]
16. Effect of obesity on platelet reactivity and response to low-dose aspirin. Bordeaux BC, Qayyum R, Yanek LR, Vaidya D, Becker LC, Faraday N, Becker DM. Prev Cardiol; 2010 Jul 16; 13(2):56-62. PubMed ID: 20377806 [Abstract] [Full Text] [Related]
17. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kapłon-Cieślicka A, Rosiak M, Postuła M, Serafin A, Kondracka A, Opolski G, Filipiak KJ. Kardiol Pol; 2013 Jul 16; 71(9):893-902. PubMed ID: 24065375 [Abstract] [Full Text] [Related]
18. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin. Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M. Am J Cardiol; 2008 Aug 15; 102(4):396-400. PubMed ID: 18678294 [Abstract] [Full Text] [Related]
19. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. Anzellotti P, Capone ML, Jeyam A, Tacconelli S, Bruno A, Tontodonati P, Di Francesco L, Grossi L, Renda G, Merciaro G, Di Gregorio P, Price TS, Garcia Rodriguez LA, Patrignani P. Arthritis Rheum; 2011 Mar 15; 63(3):850-9. PubMed ID: 21360514 [Abstract] [Full Text] [Related]
20. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Platelets; 2011 Mar 15; 22(3):188-95. PubMed ID: 21231857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]